The Food and Drug Administration on Monday approved Solco Healthcare's duloxetine delayed-release capsules.
Here are three things to know.
- Duloxetine is used to treat major depressive disorder, general anxiety disorder and fibromyalgia.
- The drug represents a generic version of Eli Lilly's Cymbalta.
- Both brand name and generic sales of duloxetine hit $484.4 million for the 12 months ending in June 2017, according to data from QuintilesIMS.
More articles on supply chain:
US Bioservices to pay $13.4M to resolve kickback suit
Patients brace for price of 'breakthrough' leukemia drug CTL019
Price of first FDA-approved ALS treatment in 20 years limits patient access at VCU Medical Center